Position in ADMA
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$9,818,285
-$9,555,700 QoQ
Shares Held
1,173,033
-45.4% QoQ
Ownership
0.524%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#37
of 323 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 89%
Shared 0%
None 11%
Common Shares in ADMA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026UBS Group AG holds $8,751,270,183 across 562 Biotechnology names. ADMA ranks #115 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
5,450,825 | $1,020,369,609 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
17,466,641 | $618,144,423 | |
| 3 | PTGX |
Protagonist Therapeutics, Inc
|
3,399,221 | $416,676,508 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
712,259 | $353,800,411 | |
| 5 | MRNA |
Moderna, Inc.
|
4,463,211 | $312,558,664 | |
| 6 | INSM |
INSMED Inc
|
2,584,446 | $275,553,630 | |
| 7 | ABVX |
Abivax S.A.
|
1,844,918 | $245,853,771 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
401,708 | $215,697,109 |
All Filings in ADMA
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,818,285 | 1,173,033 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $19,373,985 | 2,150,276 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $83,344,815 | 4,569,343 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $29,139,285 | 1,987,673 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $44,097,752 | 2,421,623 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $55,885,588 | 2,816,814 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $17,217,432 | 1,003,932 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $8,349,922 | 417,705 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $4,180,615 | 373,937 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $3,731,844 | 565,431 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $2,252,310 | 498,299 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $816,737 | 228,139 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $1,047,760 | 283,946 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $1,271,205 | 384,050 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $2,104,930 | 542,508 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $154,134 | 63,430 | Shares | Sole | 2022-11-10 | |
| 2022-03-31 | $20,852 | 11,395 | Shares | Sole | 2022-05-16 | |
| 2021-09-30 | $20,831 | 18,435 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $7,960 | 4,975 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $35,926 | 20,413 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $42,658 | 21,876 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $9,923 | 4,152 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $108,820 | 37,140 | Shares | Sole | 2020-07-31 | |
| 2020-03-31 | $100,609 | 34,934 | Shares | Defined | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||